As a triple receptor agonist targeting GLP-1, GIP, and glucagon pathways simultaneously, it produced weight reduction numbers in clinical trials that made even seasoned researchers pause
rhGH was first developed by the American biotechnology company Genentech in 1981
Mood changes are reported by thousands globally
Under the new situation, Chuangxin Biotech has developed a unique approach, with the purpose of "making conscience medicine, reassuring drugs", carrying forward the traditional Chinese medicine, and improving the quality of livestock and poultry meat and eggs through traditional Chinese medicine health care and prevention methods, making treatment a redundant behavior, makes Green meat, eggs, milk and fish to come to the tables of the people of the world, and Chuangxin will surely stand out in the veterinary medicine industry